Insulin Therapy for Adult Patients with Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association, 2017

The Korean Diabetes Association (KDA) has regularly updated its Clinical Practice Guidelines. In 2017, the KDA published a position statement on the use of antihyperglycemic agents for patients with type 2 diabetes mellitus (T2DM). Growing evidence from new multinational clinical trials using novel...

Full description

Saved in:
Bibliographic Details
Published in:Diabetes & metabolism journal 2017, 41(5), 163, pp.367-373
Main Authors: Lee, Byung Wan, Kim, Jin Hwa, Ko, Seung Hyun, Hur, Kyu Yeon, Kim, Nan Hee, Rhee, Sang Youl, Kim, Hyun Jin, Moon, Min Kyong, Park, Seok O, Choi, Kyung Mook
Format: Article
Language:English
Subjects:
Clinical practice guideline
Diabetes mellitus, type 2
Hypoglycemic agents
Insulin
Korea
Review
내과학
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The Korean Diabetes Association (KDA) has regularly updated its Clinical Practice Guidelines. In 2017, the KDA published a position statement on the use of antihyperglycemic agents for patients with type 2 diabetes mellitus (T2DM). Growing evidence from new multinational clinical trials using novel and traditional insulin analogues has also been accumulated. Following global trends, many results of clinical trials, especially concerning the clinical efficacy and safety of insulin therapy, have been published about Korean patients with T2DM. After a systematic search of recent evidence, the KDA updated and modified its clinical practice recommendations regarding the initiation, choice, and intensification of insulin and created an insulin treatment algorithm for the first time to guide physicians caring for adult Korean patients with T2DM.
ISSN:2233-6079
2233-6087
DOI:10.4093/dmj.2017.41.5.367